Vilanterol and Fluticasone furoate is indicated for:
Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)
Fluticasone furoate/vilanterol fixed-dose combination is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate:
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Fluticasone furoate/vilanterol fixed-dose combination is indicated for the symptomatic treatment of adults with COPD with a FEV1 <70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Vilanterol and Fluticasone furoate is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.